{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:09:46Z","timestamp":1790197786899,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Horizontal Project of the First Affiliated Hospital of Yangtze University."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01651-9","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T01:28:36Z","timestamp":1752888516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ALKBH5-mediated NPC2 mRNA m6A demethylation promotes resistance to oxaliplatin in colorectal cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Peng","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"crossref","unstructured":"Akagi T, Inomata M (2020) Essential updates 2018\/2019: Essential advances in surgical and adjuvant therapies for colorectal cancer. Annals Gastroenterological Surg 4: 39\u201346","DOI":"10.1002\/ags3.12307"},{"key":"1651_CR2","doi-asserted-by":"crossref","unstructured":"Bianchi G, Martella R, Ravera S, Marini C, Capitanio S, Orengo A, Emionite L, Lavarello C, Amaro A, Petretto A et al (2015) fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models. Oncotarget 6: 11806\u201311819","DOI":"10.18632\/oncotarget.3688"},{"key":"1651_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.omto.2021.01.001","volume":"20","author":"P Chen","year":"2021","unstructured":"Chen P, Liu X-q, Lin X, Gao L-y, Zhang S, Huang X (2021) Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism. Mol Therapy-Oncolytics 20:228\u2013239","journal-title":"Mol Therapy-Oncolytics"},{"key":"1651_CR4","doi-asserted-by":"crossref","unstructured":"Clough E, Barrett T (2016) The gene expression omnibus database. Stat Genomics: Methods Protocols 1418:93\u2013110","DOI":"10.1007\/978-1-4939-3578-9_5"},{"key":"1651_CR5","doi-asserted-by":"crossref","unstructured":"Escalante PI, Quinones LA & Contreras HR (2021) Epithelial-mesenchymal transition and MicroRNAs in colorectal cancer chemoresistance to FOLFOX. Pharmaceutics 13: 75","DOI":"10.3390\/pharmaceutics13010075"},{"key":"1651_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/15548627.2023.2275501","volume":"20","author":"F Geng","year":"2024","unstructured":"Geng F, Guo D (2024) SREBF1\/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth. Autophagy 20:1183\u20131185","journal-title":"Autophagy"},{"key":"1651_CR7","first-page":"4542","volume":"12","author":"T Guo","year":"2020","unstructured":"Guo T, Liu D-F, Peng S-H, Xu A-M (2020) ALKBH5 promotes colon cancer progression by decreasing methylation of the LncRNA NEAT1. Am J Translational Res 12:4542","journal-title":"Am J Translational Res"},{"key":"1651_CR8","doi-asserted-by":"crossref","unstructured":"Jensen NF, Stenvang J, Beck MK, Han\u00e1kov\u00e1 B, Belling KC, Do KN, Viuff B, Nyg\u00e5rd SB, Gupta R, Rasmussen MH et al (2015) establishment and characterization of models of chemotherapy resistance in colorectal cancer: towards a predictive signature of chemoresistance. Mol Oncol 9 1169\u20131185","DOI":"10.1016\/j.molonc.2015.02.008"},{"key":"1651_CR9","doi-asserted-by":"crossref","unstructured":"Li T, Hu P-S, Zuo Z, Lin J-F, Li X, Wu Q-N, Chen Z-H, Zeng Z-L, Wang F Zheng J (2019) METTL3 facilitates tumor progression via an m 6 A-IGF2BP2-dependent mechanism in colorectal carcinoma. Molecular Cancer 18: 1\u201315","DOI":"10.1186\/s12943-019-1038-7"},{"key":"1651_CR10","doi-asserted-by":"crossref","unstructured":"Martinez-Balibrea E, Mart\u00ednez-Card\u00fas A, Gin\u00e9s A, Ruiz de Porras V, Moutinho C, Layos L, Manzano JL, Bug\u00e9s C, Bystrup S Esteller M (2015) Tumor-related molecular mechanisms of oxaliplatin resistance. Mol Cancer Ther 14: 1767\u20131776","DOI":"10.1158\/1535-7163.MCT-14-0636"},{"key":"1651_CR11","doi-asserted-by":"crossref","unstructured":"Mukherjee S, Maxfield FR (2004) Lipid and cholesterol trafficking in NPC. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1685: 28\u201337","DOI":"10.1016\/j.bbalip.2004.08.009"},{"key":"1651_CR12","doi-asserted-by":"crossref","unstructured":"Nagy \u00c1, L\u00e1nczky A, Menyh\u00e1rt O, Gy\u0151rffy B (2018) validation of MiRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep 8: 9227","DOI":"10.1038\/s41598-018-27521-y"},{"key":"1651_CR13","doi-asserted-by":"crossref","unstructured":"Nie S, Zhang L, Liu J, Wan Y, Jiang Y, Yang J, Sun R, Ma X, Sun G Meng H (2021) ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. J Experimental Clin Cancer Res 40: 1\u201318","DOI":"10.1186\/s13046-021-02088-1"},{"key":"1651_CR14","doi-asserted-by":"crossref","unstructured":"O\u2019Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American joint committee on Cancer sixth edition staging. J Natl Cancer Inst 96: 1420\u20131425","DOI":"10.1093\/jnci\/djh275"},{"key":"1651_CR15","doi-asserted-by":"crossref","unstructured":"Qi F-f, Yang Y, Zhang H, Chen H (2020) long non-coding rnas: key regulators in oxaliplatin resistance of colorectal cancer. Biomed Pharmacother 128: 110329","DOI":"10.1016\/j.biopha.2020.110329"},{"key":"1651_CR16","doi-asserted-by":"crossref","unstructured":"Qu J, Yan H, Hou Y, Cao W, Liu Y, Zhang E, He J Cai Z (2022) RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol 15: 8","DOI":"10.1186\/s13045-022-01224-4"},{"key":"1651_CR17","doi-asserted-by":"crossref","unstructured":"Ruiz de Porras V, Bystrup S, Mart\u00ednez-Card\u00fas A, Pluvinet R, Sumoy L, Howells L, James MI, Iwuji C, Manzano JL, Layos L et al (2016) Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine\/NF-\u03baB signalling pathway. Sci Rep 6: 24675","DOI":"10.1038\/srep24675"},{"key":"1651_CR18","doi-asserted-by":"crossref","unstructured":"Shao Y, Liu Z, Song X, Sun R, Zhou Y, Zhang D, Sun H, Huang J, Wu C Gu W (2023) ALKBH5\/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation. Clin Translational Med 13: e1318","DOI":"10.1002\/ctm2.1318"},{"key":"1651_CR19","doi-asserted-by":"crossref","unstructured":"Shen D, Lin J, Xie Y, Zhuang Z, Xu G, Peng S, Tang G, Bai L, Zhu M, Zhang Y (2023) RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2\u2010dependent manner. Clin Translational Med 13 e1279","DOI":"10.1002\/ctm2.1279"},{"key":"1651_CR20","doi-asserted-by":"crossref","unstructured":"Shriwas O, Priyadarshini M, Samal SK, Rath R, Panda S, Das Majumdar SK, Muduly DK, Botlagunta M Dash R (2020) DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m 6 A-demethylation of FOXM1 and NANOG. Apoptosis 25: 233\u2013246","DOI":"10.1007\/s10495-020-01591-8"},{"key":"1651_CR21","doi-asserted-by":"crossref","unstructured":"Sleat DE, Wiseman JA, El-Banna M, Price SM, Verot L, Shen MM, Tint GS, Vanier MT, Walkley SU Lobel P (2004) Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proceedings of the National Academy of Sciences 101: 5886\u20135891","DOI":"10.1073\/pnas.0308456101"},{"key":"1651_CR22","first-page":"671","volume":"1791","author":"J Storch","year":"2009","unstructured":"Storch J, Xu Z (2009) Niemann\u2013Pick C2 (NPC2) and intracellular cholesterol trafficking. Biochim Et Biophys Acta (BBA)-Molecular Cell Biology Lipids 1791:671\u2013678","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Biology Lipids"},{"key":"1651_CR23","doi-asserted-by":"crossref","unstructured":"Suk F-M, Wang Y-H, Chiu W-C, Liu C-F, Wu C-Y, Chen T-L, Liao Y-J (2021) Secretory NPC2 protein-mediated free cholesterol levels were correlated with the sorafenib response in hepatocellular carcinoma. International journal of molecular sciences 22 8567","DOI":"10.3390\/ijms22168567"},{"key":"1651_CR24","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71: 209\u2013249","DOI":"10.3322\/caac.21660"},{"key":"1651_CR25","doi-asserted-by":"crossref","unstructured":"Tan Y-T, Li T, Wang R-B, Liu Z-K, Ma M-Y, Huang R-Z, Mo H-Y, Luo S-Y, Lin J-F, Xu R-H (2024) WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis. Cancer Lett 604: 217254","DOI":"10.1016\/j.canlet.2024.217254"},{"key":"1651_CR26","doi-asserted-by":"crossref","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47:W556\u2013W560","DOI":"10.1093\/nar\/gkz430"},{"key":"1651_CR30","doi-asserted-by":"crossref","unstructured":"Wang Y-H, Twu Y-C, Wang C-K, Lin F-Z, Lee C-Y, Liao Y-J (2018) Niemann-Pick type C2 protein regulates free cholesterol accumulation and influences hepatic stellate cell proliferation and mitochondrial respiration function. Int J Mol Sci 19:1678","DOI":"10.3390\/ijms19061678"},{"key":"1651_CR27","doi-asserted-by":"crossref","unstructured":"Wang C, Yu H, Zhuo Z, Ye Z (2023a) N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells. Heliyon 9.","DOI":"10.1016\/j.heliyon.2023.e14001"},{"key":"1651_CR29","doi-asserted-by":"crossref","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q Jia G (2014)\u00a0N 6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505: 117\u2013120","DOI":"10.1038\/nature12730"},{"key":"1651_CR28","doi-asserted-by":"crossref","unstructured":"Wang J, Qiao Y, Sun M, Sun H, Xie F, Chang H, Wang Y, Song J, Lai S Yang C (2022) FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD\/PARP1. Clinical and Translational Medicine 12.","DOI":"10.1002\/ctm2.772"},{"key":"1651_CR31","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang Y, Patel H, Chen J, Wang J, Chen Z-S Wang H (2023b) epigenetic modification of m6A regulator proteins in cancer. Mol Cancer 22: 102","DOI":"10.1186\/s12943-023-01810-1"},{"key":"1651_CR32","doi-asserted-by":"crossref","unstructured":"Wang Z-M, Ning Z-L, Ma C, Liu T-B, Tao B, Guo L (2024) low expression of lysosome-related genes KCNE1, NPC2, and SFTPD promote cancer cell proliferation and tumor associated M2 macrophage polarization in lung adenocarcinoma. Heliyon 10","DOI":"10.1016\/j.heliyon.2024.e27575"},{"key":"1651_CR33","doi-asserted-by":"crossref","unstructured":"Xu C, Shen T, Feng L, Wang L, Li S, Ding R, Geng Z, Fan M, Xiao T Zheng J (2025) FTO facilitates colorectal cancer chemoresistance via regulation of NUPR1-dependent iron homeostasis. Redox Biol 103647","DOI":"10.1016\/j.redox.2025.103647"},{"key":"1651_CR34","doi-asserted-by":"crossref","unstructured":"Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM Ellis LM (2006) chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12: 4147\u20134153","DOI":"10.1158\/1078-0432.CCR-06-0038"},{"key":"1651_CR35","doi-asserted-by":"crossref","unstructured":"Zhang Z, Wang L, Zhao L, Wang Q, Yang C, Zhang M, Wang B, Jiang K, Ye Y, Wang S (2022) N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation. Clin Translational Med 12:e940","DOI":"10.1002\/ctm2.940"},{"key":"1651_CR36","doi-asserted-by":"crossref","unstructured":"Zhao Y, Zhao H, Zhang D, Quan Q, Ge Y, Li L, Guo L (2022) YTHDF3 facilitates eIF2AK2 and eIF3A recruitment on mRNAs to regulate translational processes in oxaliplatin-resistant colorectal cancer. ACS Chem Biol 17: 1778\u20131788","DOI":"10.1021\/acschembio.2c00131"},{"key":"1651_CR37","doi-asserted-by":"crossref","unstructured":"Zhu ZM, Huo FC, Zhang J, Shan HJ Pei DS (2023) crosstalk between m6A modification and alternative splicing during cancer progression. Clin Translational Med 13: e1460","DOI":"10.1002\/ctm2.1460"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01651-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01651-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01651-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:08:33Z","timestamp":1769155713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01651-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01651-9","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures of the animal study were approved by the Medical Ethics Committee of Jing Zhou First People\u2019s Hospital (No. KY2025-017-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}